The purpose of this study is to analyze changes in the intestinal microflora of patients with COVID-19 in foreign countries and the role of microorganisms in the development of dysbacteriosis. Patients with Covid-19 usually complain of fever, cough, expectoration, shortness of breath, headache, and fatigue, but at the same time, some patients with Covid-19 experience gastrointestinal symptoms such as diarrhea, anorexia, nausea, and vomiting, complaints from the gastrointestinal trac. The literature review analyzed the etiological causes of intestinal dysbacteriosis in COVID-19. It has been established that in the intestinal microflora of patients with COVID-19, there is an increase in the number of opportunistic and pathogenic bacteria and a decrease in the number of beneficial microorganisms.

COVID-19, SARS-CoV-2

Byungchang Jin , Rajan Singx , Se Eun Ha , Xanna Zogg , Pol J Park va Seungil Ro. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. Jahon J Gastroenterol. 2021 yil 21 may; 27(19):

Chen Y, Gu S, Chen Y, Lu H, Shi D, Guo J, et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut 2021. 10.1136/gutjnl-2021-324090

Coronavirus confirmed as pandemic by World Health Organization. BBC New. URL: https://www.bbc.com/news/world-51839944

D.Fang, J.Ma, J.Guan, M.Wang, Y.Song, D.Tian, Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study, Chin J Dig, 40 2020y

Dhar D., Mohanty A. Gut Microbiota and Covid 19-Possible Link and Implications. Virus Res. 2020;285:198018.